Abstract
The study results permitted to surmise that gene HLA-B*54 class I can be considered in population as a resistant one in relation to development of oncohematological diseases. HLA-B*38, HLA-DRB1*13can be considered as genes having protective effect in relation to development of oncohematological diseases. At a given point of time, there is no statistically reliable differences in loci HLA-A, HLA-C, HLA-DQB1 that testify necessity of further investigation of HLA system in relation to oncohematological diseases.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
